Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2006
04/13/2006US20060078937 Sequencing single nucleic acid template molecules eliminates the need for amplification prior to initiation of sequencing; Long read lengths of sequence can be deduced in one run eliminating need for extensive computational methods to assemble a gap-free full length sequence of long template molecules
04/13/2006US20060078936 Solid support assay systems and methods utilizing non-standard bases
04/13/2006US20060078934 Method for acceleration and intensification of target-receptor binding and devices therefor
04/13/2006US20060078932 Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
04/13/2006US20060078926 Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
04/13/2006US20060078921 Biomarkers and expression profiles for toxicology
04/13/2006US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
04/13/2006US20060078916 HM74 and HM74a in cuboidal endothelial cells as associated with inflammation
04/13/2006US20060078912 Methods and compositions for the detection of biological molecules using a two particle complex
04/13/2006US20060078908 Multianalyte sensor
04/13/2006US20060078907 Nanomachine compositions and methods of use
04/13/2006US20060078903 Methods and compositions for the diagnosis and treatment of cyclin A-1 associated conditions
04/13/2006US20060078901 Listeria monocytogenes genome, polypeptides and uses
04/13/2006US20060078900 Using toxin induced differential gene expression profiles to evaluate toxic impact of compound, pharmaceutical agent or environmental pollutant on cells; microarray for disease diagnosis/prognosis
04/13/2006US20060078896 Method, system, and computer program product to assess properties of a chemical array
04/13/2006US20060078882 Methods for diagnosis and prognosis of cancer
04/13/2006US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
04/13/2006US20060078877 Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
04/13/2006US20060078876 Determining an antioxidant deficiency in a lymphocyte by determining a level of intracellular cysteine in the lymphocyte by measuring lymphocyte growth in a serum-free medium comprising cumene hydroperoxide and N-acetyl-L-cysteine and correlating the lymphocyte growth with the antioxidant deficiency.
04/13/2006US20060078874 Use of nuclear hormone receptors
04/13/2006US20060078873 Chip-shaped blood analysis device constituted by micro trench channels formed in an insulating substrate such as a quartz plate or a polymer resin plate; quick diagnosis of presence of an infectious disease (hepatitis, acquired immune deficiency syndrome, etc.) of the person being tested
04/13/2006US20060078756 Assembled hematin, method for forming same and method for polymerizing aromatic monomers using same
04/13/2006US20060078658 Food quality sensor and methods thereof
04/13/2006US20060078565 Nucleic acids and proteins from Group B Streptococcus
04/13/2006US20060078562 RAGE fusion proteins and methods of use
04/13/2006US20060078559 Detecting of formyl peptide receptor like-2 (FPRL2) polypeptide activity using a heme binding protein (HBP) polypeptide as a modulating agents of polypeptide activity;. antibodies against FPRL2; drug screening for treating diseases characterized by dysregulation of FPRL2 polypeptide signal transduction
04/13/2006US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python
04/13/2006US20060078550 Porcine fgl2
04/13/2006US20060078544 generating an enhanced immune response to a prostate tumor associated antigen by administering a composition comprising allogeneic cancer cells that have been rendered proliferation-incompetent and have been genetically engineered to express granulocyte-macrophage colony stimulating factor (GM-CSF)
04/13/2006US20060078539 Remedies for tumor in hematopoietic organs
04/13/2006US20060078498 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
04/13/2006US20060078468 Modification of selectivity for sensing for nanostructure device arrays
04/13/2006US20060078467 Process for distinguishing wet from dry gas with a breath alcohol measuring device
04/13/2006US20060078466 Test cards inside which sequential reactions and fluid transfer operations are performed under the effect of a control integrated therein; biochips
04/13/2006US20060078462 Bioagent detection device
04/13/2006US20060076249 Measuring device and measuring method for detecting analytes
04/13/2006US20060076246 Water electrolysis method and device for determination of hydrogen and oxygen stable isotopic composition
04/13/2006US20060076236 Fabrication of multi-sensor arrays
04/13/2006US20060075802 Method and apparatus for enhanced detection of a specie using a gas chromatograph
04/13/2006US20060075801 Device for preparing a fluid particularly a drilling mud, associated preparation method and associated analysis unit
04/13/2006DE202005020543U1 Calibration device for gas analyzers comprises holder for gas analyzer and change-over unit interacting with stop valve which is moved into open position by change-over unit when gas analyzer is inserted into holder
04/13/2006DE112004000879T5 Verfahren und Vorrichtung zur Bestimmung eines Teilchenparameters und der Prozessorleistung in einem Kohle- und Mineral-Verarbeitungssystem Method and apparatus for determining a Teilchenparameters and processor power in a coal and mineral-processing system
04/13/2006DE10320633B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus
04/13/2006DE10317400B4 EX-VIVO-Hautorganmodell aus Schweinehaut EX VIVO skin organ model from pig skin
04/13/2006DE10226072B4 Analyseverfahren zur Analyse von spezifischen Bindungsereignissen, Untersuchungsverfahren und Verwendung Analytical methods for analysis of specific binding events, the investigation method and use
04/13/2006DE102004048864A1 Analytisches Testelement mit drahtloser Datenübertragung Analytical test element with wireless data transmission
04/13/2006DE102004048856A1 In vivo measurement of body mass composition of pigs comprises measuring meat-fat ratio using electrical measuring circuit with two contacts that are electrically separated from each other
04/13/2006DE102004048462A1 Modellsystem zum Testen von pharmazeutischen Zubereitungen auf Wirksamkeit bei entzündlichen Prozessen im Nervensystem Model system to test pharmaceutical preparations for efficacy in inflammatory processes in the nervous system
04/13/2006DE102004048397A1 Typ-SGLT1-Protein-Assay Type SGLT1 protein assay
04/13/2006DE102004048396A1 Typ-EAAC1-Protein-Assay Type EAAC1 protein assay
04/13/2006DE102004048391A1 Typ-PepT1-Protein-Assay Type PepT1 protein assay
04/13/2006DE102004048316A1 On-line qualitative evaluation of germ level in circulating water of open refrigeration and air conditioning plants, by determining dynamic oxygen consumption in micro-throughflow measuring chamber
04/13/2006DE102004048045A1 Light emitting device for measuring physiological parameters on skin surface, has evaluation mechanism that compares measured physiological parameters of skin surface to produce control signals for light source
04/13/2006DE102004047965A1 Kryoeinrichtung und zugehöriges Betriebsverfahren Cryoapparatus and operating method thereof
04/13/2006DE102004047433A1 Assembly to prepare aqueous rinsing fluid for paint spray booth employing water-based paints
04/13/2006DE102004047078A1 ATR-Photometer und Photometerarray ATR-photometer and the photometer array
04/13/2006DE102004046396A1 Partikelsedimentationsvorrichtung und Verfahren zum Durchführen einer Partikelsedimentation Particle sedimentation and method for performing a particle sedimentation
04/13/2006DE10153631B4 Verfahren zum Vergleich zweier Proteinzustände Method for comparing two protein conformations
04/13/2006DE10143869B4 Vorrichtung zur Überwachung des Koagulationsstatus Device for monitoring the coagulation status
04/13/2006CA2583431A1 Variant amyloid protein
04/13/2006CA2583065A1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
04/13/2006CA2582963A1 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
04/13/2006CA2582937A1 Formulation of multivalent antibody constructs and use of same for cancer therapy
04/13/2006CA2582739A1 Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
04/13/2006CA2582683A1 Novel antibodies directed to the mammalian eag1 ion channel protein
04/13/2006CA2582022A1 Methods for the administration of iloperidone
04/13/2006CA2581041A1 Cancer markers
04/13/2006CA2579937A1 Methods for antibody library screening
04/13/2006CA2579678A1 Selective inhibitors
04/12/2006EP1645981A2 System for extracting compound differently interacting with bioactive polymer of interest
04/12/2006EP1645881A1 Screening process for the detection and characterization of protein-protein-interactions in vivo by fluorescence cross correlation spectroscopy
04/12/2006EP1645880A1 Measuring method and system
04/12/2006EP1645879A1 Screening system
04/12/2006EP1645878A2 Devices and methods for cell harvesting
04/12/2006EP1645877A1 Method for providing a insulin resistance biomarker profile of one or more lipids
04/12/2006EP1645876A2 Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
04/12/2006EP1645875A1 Diagnosis and therapy of cell proliferative disorders characterized by resistance to TRAIL induced apoptosis
04/12/2006EP1645874A1 Diffusion sensor, method of manufacturing the same and method for monitoring the progress of a diffusion prozess
04/12/2006EP1645870A1 Type identification system for diesel oil and method for identifying type of diesel oil
04/12/2006EP1645869A1 Device for recording the boiling-point curve of liquids
04/12/2006EP1645863A1 A sampling apparatus
04/12/2006EP1645635A2 Replication defective recombinant retroviruses expressing a palliative
04/12/2006EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof
04/12/2006EP1645631A2 Neisseria antigens and compositions
04/12/2006EP1645627A1 Quadruple transformed cell line useful for the identification of transport inhibitors
04/12/2006EP1645567A1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
04/12/2006EP1645284A1 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages
04/12/2006EP1645281A1 Tripterygium wilfordii Hook F root preparation for birth control
04/12/2006EP1644858A2 Expression profile algorithm and test for cancer prognosis
04/12/2006EP1644805A2 Methods and apparatus for investigating side effects
04/12/2006EP1644743A1 Thyroid hormone analysis by mass spectrometry
04/12/2006EP1644742A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1)
04/12/2006EP1644741A2 Methods and compositions for assaying homocysteine
04/12/2006EP1644740A1 Assessment of skeletal growth using measurements of nt-cnp peptides
04/12/2006EP1644739A2 Method for demonstration of a molecular event in a cell by means of fluorescent marker proteins
04/12/2006EP1644738A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES
04/12/2006EP1644737A1 Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test
04/12/2006EP1644736A1 Sensing element for a biosensor
04/12/2006EP1644735A2 Device for lateral flow tests
04/12/2006EP1644734A2 Method for assaying protein-protein interaction